BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37841260)

  • 1. Upregulated Fcrl5 disrupts B cell anergy and causes autoimmune disease.
    Ono C; Tanaka S; Myouzen K; Iwasaki T; Ueda M; Oda Y; Yamamoto K; Kochi Y; Baba Y
    Front Immunol; 2023; 14():1276014. PubMed ID: 37841260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erratum: Upregulated Fcrl5 disrupts B cell anergy and causes autoimmune disease.
    Frontiers Production Office
    Front Immunol; 2023; 14():1356364. PubMed ID: 38259460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered toll-like receptor responsiveness underlies a dominant heritable defect in B cell tolerance in autoimmune New Zealand Black mice.
    Clark AG; Buckley ES; Foster MH
    Eur J Immunol; 2018 Mar; 48(3):492-497. PubMed ID: 29251774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells.
    Li H; Borrego F; Nagata S; Tolnay M
    J Immunol; 2016 May; 196(10):4064-74. PubMed ID: 27076679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-cell anergy is maintained in anti-DNA transgenic NZB/NZW mice.
    Kat I; Makdasi E; Fischel R; Eilat D
    Int Immunol; 2010 Feb; 22(2):101-11. PubMed ID: 20038519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silica Exposure Differentially Modulates Autoimmunity in Lupus Strains and Autoantibody Transgenic Mice.
    Foster MH; Ord JR; Zhao EJ; Birukova A; Fee L; Korte FM; Asfaw YG; Roggli VL; Ghio AJ; Tighe RM; Clark AG
    Front Immunol; 2019; 10():2336. PubMed ID: 31632407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ikaros prevents autoimmunity by controlling anergy and Toll-like receptor signaling in B cells.
    Schwickert TA; Tagoh H; Schindler K; Fischer M; Jaritz M; Busslinger M
    Nat Immunol; 2019 Nov; 20(11):1517-1529. PubMed ID: 31591571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium Signaling: From Normal B Cell Development to Tolerance Breakdown and Autoimmunity.
    Hemon P; Renaudineau Y; Debant M; Le Goux N; Mukherjee S; Brooks W; Mignen O
    Clin Rev Allergy Immunol; 2017 Oct; 53(2):141-165. PubMed ID: 28500564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of peripheral B cell tolerance by CD72 in a murine model.
    Li DH; Winslow MM; Cao TM; Chen AH; Davis CR; Mellins ED; Utz PJ; Crabtree GR; Parnes JR
    Arthritis Rheum; 2008 Oct; 58(10):3192-204. PubMed ID: 18821699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin, systemic lupus erythematosus, and autoreactive B cells: lessons learnt from murine models.
    Saha S; Tieng A; Pepeljugoski KP; Zandamn-Goddard G; Peeva E
    Clin Rev Allergy Immunol; 2011 Feb; 40(1):8-15. PubMed ID: 19937157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breakdown of self-tolerance and the pathogenesis of autoimmunity.
    Ring GH; Lakkis FG
    Semin Nephrol; 1999 Jan; 19(1):25-33. PubMed ID: 9952278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic models of tolerance and autoimmunity: with special reference to systemic lupus erythematosus.
    Ravirajan CT; Isenberg DA
    Lupus; 2002; 11(12):843-9. PubMed ID: 12529049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polygenic autoimmune disease risk alleles impacting B cell tolerance act in concert across shared molecular networks in mouse and in humans.
    Harley ITW; Allison K; Scofield RH
    Front Immunol; 2022; 13():953439. PubMed ID: 36090990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Checkpoints in lymphocyte development and autoimmune disease.
    von Boehmer H; Melchers F
    Nat Immunol; 2010 Jan; 11(1):14-20. PubMed ID: 20016505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell receptor induced Fc receptor-like 5 expression is mediated by multiple signaling pathways converging on NF-κB and NFAT.
    Damdinsuren B; Dement-Brown J; Li H; Tolnay M
    Mol Immunol; 2016 May; 73():112-21. PubMed ID: 27065451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fc receptor-like 4 and 5 define human atypical memory B cells.
    Li H; Dement-Brown J; Liao PJ; Mazo I; Mills F; Kraus Z; Fitzsimmons S; Tolnay M
    Int Immunol; 2020 Nov; 32(12):755-770. PubMed ID: 32805738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired B cell anergy is not sufficient to breach tolerance to nuclear antigen in Vκ8/3H9 lupus-prone mice.
    Manion KP; Baglaenko Y; Chang NH; Talaei N; Wither JE
    PLoS One; 2020; 15(7):e0236664. PubMed ID: 32722684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD21 and FCRL5 form a receptor complex with robust B-cell activating capacity.
    Franco A; Kraus Z; Li H; Seibert N; Dement-Brown J; Tolnay M
    Int Immunol; 2018 Nov; 30(12):569-578. PubMed ID: 30107486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fc receptors and their role in immune regulation and autoimmunity.
    Takai T
    J Clin Immunol; 2005 Jan; 25(1):1-18. PubMed ID: 15742153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-β3 production.
    Morita K; Okamura T; Inoue M; Komai T; Teruya S; Iwasaki Y; Sumitomo S; Shoda H; Yamamoto K; Fujio K
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):E8131-E8140. PubMed ID: 27911796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.